Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease

Mariantonia Maglio, Fabiana Ziberna, Rosita Aitoro, Valentina Discepolo, Giuliana Lania, Virginia Bassi, Erasmo Miele, Tarcisio Not, Tarcisio Not, Riccardo Troncone, Riccardo Troncone, Renata Auricchio, Renata Auricchio

Research output: Contribution to journalArticlepeer-review


© 2017 by the authors. Licensee MDPI, Basel, Switzerland. It has been hypothesized that gluten-dependent production of anti-tissue-transglutaminase 2 (anti-TG2) antibodies may occur only at an intestinal level. We have investigated intestinal production of anti-TG2 antibodies in 136 patients with normal serum levels of anti-TG2 antibodies and normal duodenal mucosa. Intestinal deposits of anti-TG2 antibodies were evaluated by immunofluorescence and anti-TG2 antibodies released in organ culture supernatants measured by ELISA. Intestinal antibody libraries were obtained from 10 subjects. Immunohistochemistry for CD25 + , CD3 + , and TCR-γδ + was assessed in subjects with positive (n = 32) and negative (n = 31) intestinal anti-TG2 antibodies. Globally 33/136 (24%) seronegative patients produced anti-TG2 autoantibodies at an intestinal level. Antibody libraries analysis confirmed the anti-TG2 antibodies mucosal production in all (n = 8) positive subjects. Lamina propria CD25 + cell count was significantly (p < 0.05) higher in patients with intestinal anti-TG2. Moreover, 13/32 (41%) of them showed high TCR-γδ + /CD3 + ratios. Intestinal anti-TG2 antibody production does not show absolute specificity for CD. It is seen more often in association with inflamed mucosa. Further investigations are necessary to prove the possible role of dietary gluten.
Original languageEnglish
Issue number10
Publication statusPublished - Oct 1 2017


  • Celiac disease
  • Intestinal anti-transglutaminase 2 antibodies
  • Potential celiac disease
  • TCR-γδ intraepithelial lymphocytes +


Dive into the research topics of 'Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease'. Together they form a unique fingerprint.

Cite this